PLOS one publication
Stemina Biomarker Discovery, Inc. today announced the publication of research conducted in collaboration with the MIND Institute at the University of California-Davis to identify biomarkers in the blood of children with autism spectrum disorders (ASD) that can distinguish them from typically developing children. The research is the first of its kind and has the potential to enable earlier diagnosis and treatment of children with ASD from a blood sample.
- Do you have questions on how to get started with the NPDX AA test, which helps children receive an earlier diagnosi… https://t.co/KeWp0ufkWe2 days ago
- It’s important to start intervention for #autism as early as possible. But what if that doesn’t happen? New researc… https://t.co/ro2MGxjlGb2 days ago
- The NPDX AA test can help children who have already been diagnosed by giving doctors metabolic information that cou… https://t.co/h943OZueZb3 days ago